Top Story

7 recent FDA updates you may have missed

September 20, 2019

Alcoholic hepatitis drug candidate shows ‘life-saving potential’

September 20, 2019
Data from a phase 2a clinical trial of DUR-928, an endogenous, small-molecule new chemical entity, for patients with alcoholic hepatitis demonstrated that the treatment…
In the Journals

Australia will miss HBV elimination targets despite improved care

September 19, 2019
Results from an estimation model revealed that Australia will marginally miss both its local targets and the WHO’s global targets for eliminating chronic hepatitis…
In the Journals

H. pylori treatment, vitamins, garlic reduce gastric cancer mortality

September 17, 2019
Over the course of 22 years of follow-up, treatment for Helicobacter pylori infection, as well as vitamin and garlic supplementation, reduced the risk for death due to…
More Headlines »